The research output of rod-cone dystrophy genetics.
Human development index
Next-generation sequencing
Research output
Rod-cone dystrophy
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
23 04 2022
23 04 2022
Historique:
received:
15
04
2021
accepted:
09
04
2022
entrez:
24
4
2022
pubmed:
25
4
2022
medline:
27
4
2022
Statut:
epublish
Résumé
Non-syndromic rod-cone dystrophy (RCD) is the most common condition in inherited retinal diseases. The aim of this study was to evaluate the research output and productivity related to RCD genetics per countries as classified by the human development index (HDI), by analyzing publication frequency and citations, the choice of journals and publishers, since 2000 to date. We have also analyzed the use of next-generation sequencing (NGS) in publications originating from countries with different HDIs. One thousand four hundred articles focusing on non-syndromic RCD were downloaded and analyzed. Citations and published articles were adjusted per one million individuals. The research output is significantly higher in very high HDI countries (86% of the total publications and 95% of the citations) than countries with lower HDIs in all aspects. High and medium HDI countries published together 13.6% of the total articles worldwide and received 4.6% of the citations. On the publication level, the USA (26%), United Kingdom (10%), and Japan (7%) were the top 3 among very high HDI countries, while China (6%) and India (2%) ranked first in high and medium HDI countries respectively. On the citation level, similar profiles were found. Following adjustment for population size, Switzerland (~14%), Jordan (~ 1%) and Morocco (<0.2%) showed the highest rates of publications in very high, high and medium HDI countries respectively. Very high HDI countries published 71% of their papers in first quartile journals (first quartile in Scimago journal rank; Q1), and 23% in Q2 journals. High and medium HDI countries showed a similar profile in quartiles with ~ 40% of their papers published in Q1 journals and ~ 30% in Q2 journals. The first publication using NGS was issued in 2009 in very high HDI countries, while it appeared in 2012 in high HDI countries, and in 2017 in medium HDI countries, with a respective lag of 3 to 8 years compared to very high HDI countries. A profound gap exists between very high HDI countries and the rest of the world. To fill it in, we propose implementing NGS, supporting international collaborations, building capacities and infrastructures, improving accessibility of patients to services, and increasing national and international funding.
Identifiants
pubmed: 35461258
doi: 10.1186/s13023-022-02318-5
pii: 10.1186/s13023-022-02318-5
pmc: PMC9034540
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
175Informations de copyright
© 2022. The Author(s).
Références
Biomed Res Int. 2015;2015:261329
pubmed: 25961008
Ann Med Surg (Lond). 2021 May 26;66:102441
pubmed: 34123378
Biopreserv Biobank. 2018 Jun;16(3):171-178
pubmed: 29668303
Global Health. 2017 Nov 6;13(1):80
pubmed: 29110668
Mol Genet Genomic Med. 2016 Nov 10;4(6):588-598
pubmed: 27896281
BMJ Open. 2015 Dec 30;5(12):e008993
pubmed: 26719313
PLoS One. 2015 May 20;10(5):e0125915
pubmed: 25993307
Br J Ophthalmol. 2006 Mar;90(3):279-84
pubmed: 16488944
Soc Sci Med. 2020 Nov;265:113449
pubmed: 33183862
Adv Bioinformatics. 2015;2015:303605
pubmed: 26880910
BMC Int Health Hum Rights. 2012 Oct 22;12:23
pubmed: 23088820
Int J Prev Med. 2011 Oct;2(4):203-15
pubmed: 22174959
Prog Retin Eye Res. 2017 Jul;59:53-96
pubmed: 28363849
Lancet. 2008 Feb 9;371(9611):464
pubmed: 18271083
Pract Neurol. 2015 Dec;15(6):474-8
pubmed: 26386028
Biomed Res Int. 2015;2015:545243
pubmed: 25692141
BMC Med Res Methodol. 2006 Aug 01;6:37
pubmed: 16879753
BMC Health Serv Res. 2017 Nov 17;17(1):741
pubmed: 29149852
Per Med. 2014 Jul;11(5):487-496
pubmed: 29758778
Science. 2008 Jul 25;321(5888):522-5
pubmed: 18653879
Gene Ther. 2017 Sep;24(9):562-571
pubmed: 28440796
Appl Transl Genom. 2016 Mar 10;9:15-9
pubmed: 27354935
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15739-46
pubmed: 16263937
Hum Mol Genet. 2014 Jan 15;23(2):491-501
pubmed: 24026677
Br J Ophthalmol. 2008 May;92(5):650-4
pubmed: 18356260
J Pers Med. 2018 Sep 21;8(4):
pubmed: 30248964
Med J Aust. 2002 Oct 7;177(7):368-71
pubmed: 12358580
Aust N Z J Ophthalmol. 1992 Nov;20(4):311-7
pubmed: 1295526
Eur J Hum Genet. 2017 Dec;25(12):1293-1302
pubmed: 29158551
Nat Commun. 2017 Nov 6;8(1):1326
pubmed: 29109544
Account Res. 2020 Nov;27(8):477-495
pubmed: 32515609
Orphanet J Rare Dis. 2006 Oct 11;1:40
pubmed: 17032466
Genet Epidemiol. 1995;12(1):37-46
pubmed: 7713399
Genet Med. 2020 Jan;22(1):85-94
pubmed: 31358947
Curr Med Chem. 2018 Jan 30;25(3):404-432
pubmed: 28721829
J Clin Orthop Trauma. 2020 Oct 22;14:14-16
pubmed: 33680812
Am J Ophthalmol. 1984 Mar;97(3):357-65
pubmed: 6702974
iScience. 2020 Apr 24;23(4):100971
pubmed: 32203907
Nature. 2011 Feb 3;470(7332):6
pubmed: 21293330
EMBO Rep. 2007 Feb;8(2):112-6
pubmed: 17268499
Sci Rep. 2019 Feb 4;9(1):1219
pubmed: 30718709
AJR Am J Roentgenol. 2004 Dec;183(6):1545-50
pubmed: 15547189
Biopreserv Biobank. 2013 Dec;11(6):339-46
pubmed: 24835363
Clin Genet. 2019 Feb;95(2):329-333
pubmed: 30267408
Eur J Hum Genet. 2021 Jun;29(6):897-910
pubmed: 33188265
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Trop Med Int Health. 2019 Mar;24(3):264-279
pubmed: 30565381
Am J Hum Genet. 2014 Apr 3;94(4):625-33
pubmed: 24680887
PLoS One. 2018 Mar 26;13(3):e0194805
pubmed: 29579088